Cencora, Inc. (BMV:COR)

Market Cap	1.05T
Revenue (ttm)	5.97T
Net Income (ttm)	35.78B
Shares Out	n/a
EPS (ttm)	182.49
PE Ratio	29.42
Forward PE	17.19
Dividend	33.76 (0.61%)
Ex-Dividend Date	May 16, 2025

Volume	363
Average Volume	417
Open	5,545.77
Previous Close	n/a
Day's Range	5,545.77 - 5,545.77
52-Week Range	4,706.61 - 5,723.39
Beta	n/a
RSI	n/a
Earnings Date	Aug 6, 2025

About Accolade

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 46,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: COR

Financial Performance

In 2024, Cencora's revenue was $293.96 billion, an increase of 12.12% compared to the previous year's $262.17 billion. Earnings were $1.51 billion, a decrease of -13.53%.